BUNNAGE MARK E. (EVP, Chief Scientific Officer) sold 0.5% of their position (33.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $15.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/19/2026ACC: 0000875320-26-000226
Officer· EVP, Chief Scientific Officer
Since Feb 2026
-33.00
Net shares
Net seller
$15.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
33.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−33.00
Price / share
$453.45
Trade value
$14.96K
% of position
0.5%
5/15/2026
7.32K→7.28K
Total
Net shares
−33.00
Net value
-$14.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | S · Sale | −33.00 | $453.45 | $14.96K | 0.5% | 7.32K | 7.28K |
| Total | −33.00 | -$14.96K | ||||||
Derivative Transactions0
No derivative transactions reported